Lotus Eye Hospital And Institute Ltd.
NSE: LOTUSEYE | BSE: 532998
₹135.10
₹0.87
(0.65%)
As on 12-Jun-2026IST
Market cap
₹281 Cr
Revenue (TTM)
₹54 Cr
P/E Ratio
3463.5
P/B Ratio
4.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
1.2 %
-
ROCE
3.1 %
-
Industry P/E
3,463.49
-
EV/EBITDA
63.2
-
Debt to Equity
0.2
-
Book Value
₹28.9
-
EPS
₹0
-
Face value
10
-
Shares outstanding
20,796,330
10 Years Aggregate
CFO
₹41.22 Cr
EBITDA
₹45.52 Cr
Net Profit
₹16.35 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Lotus Eye Hosp
| 13.3 | 20.0 | 25.3 | 87.5 | 18.1 | 24.8 | 22.8 |
|
BSE Healthcare
| 9.1 | 1.2 | 7.9 | 7.7 | 25.1 | 13.2 | 12.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Lotus Eye Hosp
| 72.4 | -20.9 | 8.9 | 47.5 | 50.9 | 43.5 | -21.2 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Lotus Eye Hosp
|
135.1 | 280.5 | 53.7 | 0.1 | -0.7 | 0.1 | 3463.5 | 4.7 |
| 120.0 | 123.5 | 25.0 | 0.1 | -0.3 | 0.4 | 2375.3 | 10.1 | |
| 815.0 | 42,224.3 | 4,643.2 | 464.1 | 13.7 | 8.9 | 108.8 | 9.2 | |
| 439.8 | 13,950.4 | 2,080.1 | 168.1 | 14.1 | 6.7 | 104.7 | 6.9 | |
| 1,601.5 | 26,830.4 | 2,762.9 | 509.8 | 22.5 | 21.5 | 53.2 | 10.7 | |
| 10.8 | 11.4 | 0.0 | -1.7 | -- | -7.2 | -- | 0.5 | |
| 785.1 | 31,494.9 | 3,904.6 | 239.4 | 13.3 | 11.1 | 130.5 | 14.0 | |
| 117.6 | 39.4 | 16.4 | 1.7 | 7.3 | 4.8 | 22.7 | 1.2 | |
| 16.8 | 38.2 | 0.0 | -8.7 | -48,411.1 | -66.4 | -- | 3.3 | |
| 73.0 | 31.1 | 26.3 | -2.7 | -5.4 | -- | -- | -22.1 |
Shareholding Pattern
View DetailsNews & Analysis
All News
3 min read•By Research Desk
About Lotus Eye Hosp
Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik... eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments. It provides treatment services for various eye problems, such as refractive, cataract, glaucoma, retinal disease/diabetic eye care, neuro ophthalmology, binocular vision, and cornea infections, as well as various eye related courses. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India. Read more
-
Incorporated
1997
-
Chairman
Kavetha Sundaramoorthy
-
Managing Director
Sangeetha Sundaramoorthy
-
Headquarters
Coimbatore, Tamil Nadu
-
Website
Looking for more details about Lotus Eye Hospital And Institute Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Lotus Eye Hosp
What is the current share price of Lotus Eye Hospital And Institute Ltd Today?
The share price of Lotus Eye Hospital And Institute Ltd is ₹135.10 (NSE) and ₹134.90 (BSE) as of 12-Jun-2026 IST. Lotus Eye Hospital And Institute Ltd has given a return of 18.13% in the last 3 years.
What is the current PB & PE ratio of Lotus Eye Hospital And Institute Ltd?
Since, TTM earnings of Lotus Eye Hospital And Institute Ltd is negative, P/E ratio is not available.
The P/B ratio of Lotus Eye Hospital And Institute Ltd is 4.67 times as on 12-Jun-2026, a 41 premium to its peers’ median range of 3.32 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
196.62
|
2.42
|
|
2024
|
40.31
|
1.98
|
|
2023
|
29.62
|
2.10
|
|
2022
|
37.18
|
2.03
|
|
2021
|
55.57
|
1.65
|
What is the 52 Week High and Low of Lotus Eye Hospital And Institute Ltd?
The 52-week high and low of Lotus Eye Hospital And Institute Ltd are Rs 147.00 and Rs 67.72 as of 14-Jun-2026.
What is the market cap of Lotus Eye Hospital And Institute Ltd?
Lotus Eye Hospital And Institute Ltd has a market capitalisation of ₹ 281 Cr as on 12-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Lotus Eye Hospital And Institute Ltd?
Before investing in Lotus Eye Hospital And Institute Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.